Olmis A 5/40mg Tablet

Olmis A 5/40mg Tablet is a medication that combines two active ingredients: Olmesartan & Amlodipine. Olmesartan belongs to the class of angiotensin II receptor blockers (ARBs), while Amlodipine is a calcium channel blocker (CCB). This combination tablet is used to manage hypertension (high blood pressure) by helping to relax blood vessels and improve blood flow, thus reducing blood pressure.

Uses:

Olmis A 5/40mg Tablet is prescribed for the treatment of hypertension, either as initial therapy or for patients who require additional blood pressure control beyond monotherapy. Olmesartan works by blocking the action of angiotensin II, a hormone that narrows blood vessels, while Amlodipine relaxes and widens the blood vessels by blocking calcium influx into the smooth muscle cells of the vessel walls. Together, these medications help to lower blood pressure and reduce the risk of cardiovascular events.

Side Effects:

Common side effects associated with Olmis A 5/40mg Tablet may include dizziness, headache, swelling in the ankles or feet, flushing, fatigue, and gastrointestinal symptoms such as nausea or abdominal pain. In some cases, individuals may experience more severe side effects such as low blood pressure, allergic reactions, or liver problems. It’s essential to report any adverse reactions to a healthcare professional promptly.

Precautions:

Before taking Olmis A 5/40mg Tablet, individuals should inform their healthcare provider about any pre-existing medical conditions, allergies, or medications they are currently taking. This medication may interact with other drugs, so it’s crucial to review the patient’s medication regimen to avoid potential interactions. Patients should avoid activities requiring mental alertness, such as driving or operating machinery, until they understand how this medication affects them.

When Not to Use:

Olmis A 5/40mg Tablet is contraindicated in patients with a known hypersensitivity to Olmesartan, Amlodipine, or any other components of the medication. It should not be used during pregnancy or while breastfeeding, as it may harm the fetus or infant. Patients with severe liver disease or biliary obstruction should also avoid this medication. Individuals with a history of angioedema related to previous ACE inhibitor or ARB therapy should use Olmis A 5/40mg Tablet with caution.